Antibodies directed against a bacterial fusion protein that contains the domain encoded by the highly evolutionarily conserved 5' one-third of the v-myb oncogene of avian myeloblastosis virus (AMV) detect the protein products of various members of the myb gene family. Immunoprecipitation or immunoblot analyses with these antibodies yielded the following information. First, the products of the v-myb oncogenes of AMV (p48v-myb) and of E26 virus (p135gag-mybets) contain this highly conserved amino acid sequence, as previously hypothesized. Second, p75c mYb, the product of the chicken c-myb protooncogene, also contains this protein domain. Third, these antibodies have identified the products of the human, murine, and Drosophila c-myb genes, which were all found to be nuclear proteins of Mr 75,000-80,000. The human c-myb protein product is present in immature cells of the erythroid, myeloid, and lymphoid lineages.
The v-mybAMV product, p48v-myb ( Fig. 1) , was first identified immunologically in virally transformed cells by antisera raised against synthetic peptides deduced from the v-mybAMV DNA sequence (14) or by antiserum against the product of a v-mybAMV sequence fused to a bacterial expression vector (16) . All of these antibodies were directed against sequences encoded downstream of the first myb-specific ATG (6, 7) . The molecular weight of this nonglycosylated protein, 48,000, greatly exceeded that of the predicted Mr 30,000 protein that would have resulted from translation initiation at the first internal AUG of v-mybAMV (14, 16) . This led to the hypothesis that translation of the v-mybAMV gene product begins in the spliced gag leader sequence, as is the case for the avian retroviral env gene product (17) . Consistent with this hypothesis, nuclease S1 mapping studies of viral subgenomic mRNA identified a v-myb'v splice acceptor site that would permit the gag leader codons to be spliced in-frame to a long, myb-specific open reading frame beginning 115 codons upstream of the first internal myb-specific AUG (13) .
The same antisera initially used to identify p48v-myb were also used to identify the chicken c-myb gene product. Three anti-myb-peptide antisera reacted with a Mr 110,000 cytoplasmic protein in normal chicken thymus (18) , whereas the antiserum to the carboxyl-terminal, v-mybAMV-encoded portion of a bacterial fusion protein recognized a Mr 75,000 nuclear protein in a transformed chicken erythroid cell line (19) . Further, none of these antisera could identify mybrelated proteins in other species.
The amino acid sequence predicted to be present in p48v-myb and which is encoded upstream of the first internal myb-specific AUG codon ( Fig. 1 ) is also part of the c-myb region that is most conserved among metazoan species (6, (9) (10) (11) 20) . We have therefore raised antibodies against this amino-terminal v-myb region, after its expression as part of a bacterial fusion protein, with the following objectives: (i) to ascertain that it is present in p48v-myb of AMV and in the transforming protein p135-,myb-ets of E26 virus; (ii) to determine whether the molecular weight ofthe chicken c-myb protein is 75,000 or 110,000; and (iii) to identify the products of the c-myb gene in different metazoan species and determine their intracellular locations.
MATERIALS AND METHODS
Expression of a Conserved v-myb Domain in Escherichia coli. The conserved 5' region of the v-myb oncogene was subcloned (Fig. 2) into an inducible, high-level trpE expression vector, pATH-3, supplied to us by T. J. Koerner and A.
Tzagaloff (Columbia University, New York) using standard procedures (21) . A sample of plasmid pUCMYB (to be described elsewhere) was digested to completion with Nco I [nucleotide (nt) 233] and Xba I (nt 1311), and the resulting v-myb fragment was purified (nucleotide numbering is according to ref. 7) . Another sample of pUCMYB DNA was digested with Kpn I (nt 3) and EcoRI (nt 506), to obtain a fragment that contains the 5' end of v-myb missing in the Nco I-Xba I fragment. Purified Kpn I-EcoRI fragment was digested with Hinfl, treated with Klenow fragment of DNA polymerase, and then digested with Nco I. This yielded a small fragment blunt-ended at the Hinfl (splice acceptor) site (nt 164) and extending to the Nco I site (nt 233). This fragment was purified by gel electrophoresis and added to a ligation mixture containing the Nco I-Xba I fragment of v-myb and pUC18 DNA fragment of pUC165X into the single EcoRI site of plasmid pATH-3. The trpE-myb gene product of plasmid pA340.A, Bp52trPE-mYb (Bp52), was expressed in E. coli C600 and purified by gel electrophoresis as described (16, 22) .
Preparation of Anti-Bacterial Fusion Protein Antisera. New Zealand White rabbits were immunized by subcutaneous injections of emulsified gel slices containing 250 pmg of Bp52 protein every 2 weeks as described (16) . Anti-BpS2 antibodies were affinity-purified with 500 pug of Bp52, purified by gel electrophoresis, covalently linked to Affi-Gel 10 according to the suggestions of the manufacturer (Bio-Rad). After elution with 0.1 M glycine-HCl (pH 2.5), neutralization with Tris base, and addition of bovine serum albumin to a final concentration of 5 mg/ml, the anti-Bp52 immunoglobulin (IgG) was dialyzed against phosphate-buffered saline (0.15 M sodium chloride/15 mM sodium phosphate, pH 7.4) containing 0.01% sodium azide and then was stored at -70TC.
Rabbit anti-myb peptide 4 (P4) IgG was similarly affinitypurified, using Affi-gel 10 Moscovici (24) . Other chicken cells were isolated and cultured as described (14, 25) . Thymocytes were isolated from the thymus of 3-week-old BALB/c mice. The mouse myelomonocytic leukemia cell line WEHI-3B was provided by J. Ihle (National Cancer Institute) and cultured as described (26) . Human hematopoietic cell lines from the erythroid (K-562), myeloid (KG-1 and HL-60), and lymphoid (CEM, IM-9, and HUT 79) lineages were supplied by 0. Witte and I. Chen (University of California, Los Angeles) and cultured as described (27) . The Drosophila embryonic cell line Kc was supplied by J. D. O'Connor (University of California, Los Angeles) and cultured as described (28) .
Cell Labeling and Cell Fractionation. All cells were biosynthetically labeled with [35S]methionine as described (14) . Drosophila Kc cells were radioactively labeled in Seecoff's salt solution (pH 6.8) at 21'C. Labeled cells were fractionated into nuclei and cytoplasm, and the isolated nuclei were further fractionated into subnuclear compartments (18, 29) .
Analysis of myb-Encoded Protein and mRNA. Protein encoded by either v-myb or c-myb was immunoprecipitated from detergent-solubilized lysates of labeled cells and analyzed by NaIDodSO4/PAGE as described (14) . Poly(A)+ RNA was isolated, fractionated by electrophoresis in formaldehyde/agarose gels, and transferred to nitrocellulose (21) . myb-related transcripts were detected by hybridization with the 32P-labeled BamHI insert of plasmid pHAX-4 (30) as described (13) .
RESULTS
Presence of the Evolutionarily Conserved 5' v-myb Domain in the Oncogene Products of AMV (p48v1nYb) and E26 Virus (pl353ag-mybl)e). The highly conserved, cell-derived 5'-terminal v-mybAMv segment (Fig. 1) extending from the spliceacceptor site (Hinfl site) (13) to an EcoRI site located 9 bp 5' of the first internal ATG codon of myb (6, 7) was subcloned into an inducible, high-level trpE expression vector plasmid (Fig. 2) . This recombinant plasmid, pA340.A, should encode a protein containing a Mr 37,000 trpE-specific amino terminus fused to a Mr 15,000 myb-specific carboxyl terminus. Upon induction of the trpE operon in pA340.A-transfected bacteria, the predicted Mr 52,000 TrpE-myb fusion protein, Bp52, was produced abundantly (data not shown). Antisera from rabbits immunized with purified Bp52 protein reacted with both trpE-and myb-specific proteins, whereas the preimmunization sera did not (data not shown). Antibodies that were affinity-purified, by adsorption to and elution from a column of immobilized Bp52, specifically and solely immunoprecipitated p48v-myb from AMV-transformed myeloblasts, as did immunoaffmity-purified antiserum to v-myb carboxyl-terminal peptide (anti-P4) (Fig. 3B) . The anti-Bp52-specific antibodies immunoprecipitated p48vmYb synthesized either by a cloned AMV-transformed myeloblast line (BM2) that contains only the defective AMV provirus (Fig. 3B, lane  2) or by polyclonal AMV-transformed peripheral blood leukemic myeloblasts (Fig. 3B, lane 4) 110,000 protein that we had previously observed with antisera against short myb peptides was not detected by our anti-Bp52 antibodies. Neither was any other crossreactive protein detected. Further, p75c-myb present in chicken thymocytes was localized within the nucleus (data not shown), as is p75c-myb in AEV-transformed erythroblasts (19) , p48v-myb, or pl35gag-mybets (18, 19) . Thus, the conserved 5' domain of v-myb is also present in p75c-myb. Neither 4.0-kb c-myb mRNA nor p75c-myb protein was observed in AMV-or E26 virus-transformed hematopoietic cells (Fig. 3) .
Identification Bp52trPE-myb is highly conserved in the DNA of a wide range of species, including Drosophila, mice, and humans in addition to chickens (6, 11, 20) . We therefore examined appropriate cell lines and tissues from these metazoan species for the presence of candidate c-myb products.
In lysates prepared from adult Drosophila flies, which express a c-myb-related transcript of 3.8 kb (11), a protein of Mr 80,000 was detected by immunoblot analysis with our anti-Bp52 antibodies (data not shown). A Mr 80,000 protein was also specifically immunoprecipitated (Fig. 4A ) from whole-cell extracts of the Drosophila embryonic cell line Kc (28). 1-3) , AMVtransformed peripheral blood leukemic myeloblasts (lanes 4 and 5), chicken thymocytes (lanes 6 and 7) , or E26-transformed peripheral blood leukemic myeloblasts (lanes 8 and 9) were immunoprecipitated with affinity-purified anti-v-myb carboxyl-terminal peptide (P4) IgG (lane 1), affinity-purified anti-Bp52 IgG (lanes 2, 4, 6, and 8), or affinity-purified anti-Bp52 IgG blocked with excess Bp52 (lanes 3, 5, 7, and 9). Positions of molecular weight markers (Mr X 10-3) run in parallel are at right.
In one transformed murine myeloid cell line (WEHI-3B) and in thymocytes from a 3-week-old mouse, which express a c-myb mRNA of 4.0 kb (36, 37) a labeled protein of Mr 75,000 was specifically immunoprecipitated by anti-Bp52 antibodies (Fig. 4 C and D) . Immunoprecipitation of lysates of a human lymphoblastic cell line (CEM) revealed two molecular species of Mr 79,000 and 97,000, respectively (Fig.  4E) . However, the Mr 97,000 protein was also detected in mature B-lymphoid (IM-9) cells, which do not express myb-related mRNA (see below), and it was not associated with the nuclear matrix/lamina fraction, as is p79c-myb (Fig.   5A ).
Nuclear Localization of myb-Related Protein in Human and Drosophila Cells. The nuclear location ofthe candidate human p79c-myb and Drosophila p80c-myb further supports their relationship to the known products of the avian v-myb and c-myb genes. Subcellular fractionation and immunoprecipitation of human CEM cells, which express a high level of p79c-myb, revealed that this nuclear protein has the same distribution among the various subnuclear compartments (Fig. 5A) as does p48v-myb in chicken leukemic cells (29) . p79C-myb is tightly associated with the insoluble peripheral lamina/nuclear matrix. The remaining third is present in the soluble nucleoplasmic fraction.
Subnuclear fractionation of labeled Kc cells revealed that the putative Mr 80,000 Drosophila c-myb product has the same subnuclear compartmentalization as the products of the chicken and human myb genes and was not detected in the cytoplasm (data not shown). Further, this protein is the only molecular species immunoprecipitated by our anti-Bp52 antiserum from lysates of solubilized nuclear matrix fractions isolated from labeled Kc nuclei (Fig. SB) .
The Product of the Human c-myb Gene is Expressed in Immature Erythroid, Myeloid, and Lymphoid Hematopoietic Lineages. The presence or absence of c-myb mRNA in numerous human hematopoietic cell lines has been determined (27) , and we have analyzed a number of these cell lines for the expression of a c-myb product that contains the conserved myb domain present in Bp52. A Mr 79,000 protein was specifically immunoprecipitated from K-562 (erythroblasts), KG-1 (myeloblasts), and HL-60 (promyelocytes) cells (Fig. 5C ) as well as from CEM (lymphoblasts) cells, which express c-myb mRNA (27) , but not from (mature B-lymphocytic) or HUT 79 (mature T-lymphocytic) cells (data not shown), which do not express myb-related mRNA (27) . This pattern of p79c-myb expression correlates precisely with myb-specific mRNA (27) " lo p8OO-_,!!, p75-examined species indicates that antibodies to this antigen should crossreact with the c-myb products of other species. This 5'-terminal v-mybAMV protein coding domain is 96% identical (at the amino acid level) with the corresponding mouse c-myb domain (20) , 97% identical with chicken c-myb and v-mybE26 (5, 6) , and 71% identical with Drosophila c-myb (11) . Even between the more distantly related sequences present in the chicken and the fruit fly, several uninterrupted regions of 10-20 identical amino acids are present. The sequence of human c-myb has yet to be reported, but the amino acid sequence of the conserved domain described above is likely to be nearly identical to that of the mouse and chicken.
We have confirmed that the product of the chicken c-myb gene is a Mr 75,000 nuclear protein, as reported by others (16, 19) , and not pli0x, a hematopoietic-specific product of an unknown gene (14) . In addition, we have identified a family of myb-related nuclear proteins of Mr 75,000-80,000 in human, mouse, and Drosophila. In humans, this myb-related protein is present in immature cells of the lymphoid, erythroid, and myeloid lineages.
Our conclusion that these proteins are the products of their respective c-myb genes is based on the following observations: (i) antisera from rabbits immunized with the Bp52
TrpE-myb fusion protein immunoprecipitate p75-80c-myb, as well as p48v-myb and p135gag-myb-ets, but do not do so after preincubation with excess antigen; (ii) immunoaffinity-purified antibodies solely and specifically recognize p48VmYb, P135gag-myb-ets, and chicken p75c-mYb; (iii) detection of p75-80c-myb with our antiserum correlates precisely with expression of c-myb mRNA in various cell types; and (iv) all of these myb-sequence-containing proteins are located in the cell nucleus, as are p48v-myb and p135gag-myb-ets Further, in human and Drosophila cells a major portion of the mybrelated proteins is associated with an insoluble nuclear structure. This observed intranuclear localization, which is dependent upon the fractionation procedures used, is similar to that previously reported for the products of the v-myb, v-myc, and c-myc genes (12, 29, 37) .
